Cafepharma Today

May 30 2025 - #ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
#ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
Roche links BTK inhibitor to low relapse rate across 96-week multiple sclerosis trial
Mixed COPD results for Regeneron, Sanofi drug cloud approval chances
Illumina introduces a new AI algorithm PromoterAI
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

With pharma in ‘catbird seat,’ biotechs get less upfront in drug partnerships
BioPharma Dive
Friday, August 9, 2024 - 11:55am
tags:
biotech, licensing
Pulse Biosciences launches first-in-human pulsed field ablation trial
Clinical Trials Arena
Friday, August 9, 2024 - 11:32am
tags:
Pulse Biosciences, atrial fibrillation, pulsed field ablation, clinical trials, Medtech
Legend Biotech CEO takes ‘close look at business’ amid geopolitical risk, M&A rumor
Fierce Pharma
Friday, August 9, 2024 - 11:31am
tags:
Legend Biotech, Pharma CEOs, Ying Huang, CAR-T, Carvykti, M&A
MDMA therapy is facing an imminent FDA decision. Here’s what you need to know
Stat
Friday, August 9, 2024 - 11:29am
tags:
FDA, MDMA, psychedelics, Lykos Therapeutics, PTSD
CMS finalizes notice on Medicare coverage for breakthrough devices
Medtech Dive
Friday, August 9, 2024 - 11:27am
tags:
CMS, Medicare, Medtech, breakthrough devices
Cepheid to cut more than 600 employees in California
Medtech Dive
Friday, August 9, 2024 - 11:26am
tags:
Cepheid, layoffs, California, diagnostics, Medtech
Sandoz lifts guidance after Humira biosimilar drives another quarter of sales growth
Fierce Pharma
Friday, August 9, 2024 - 11:25am
tags:
Sandoz, earnings, biosimilars, Humira, AbbVie, Novartis
IRA Reality Check: Four Strategies for Adapting Hub and Copay Programs
Drug Channels
Friday, August 9, 2024 - 11:25am
tags:
Inflation Reduction Act, drug pricing, copays
On doorstep of FDA decision, Gilead pays J&J $320M to exit licensing deal for seladelpar
Fierce Biotech
Friday, August 9, 2024 - 11:23am
tags:
Gilead Sciences, seladelpar, liver disease, JNJ
Pharma execs react to final drug price negotiations with Medicare
Pharma Voice
Friday, August 9, 2024 - 11:21am
tags:
Medicare, drug pricing, Inflation Reduction Act, Bristol Myers Squibb, Eli Lilly, JNJ, Bayer, Merck, AstraZeneca, Novartis, Amgen, AbbVie, Novo Nordisk
Lilly's tau drug for Alzheimer's flunks phase 2 test
Pharmaphorum
Friday, August 9, 2024 - 11:18am
tags:
Eli Lilly, Alzheimer's disease, clinical trials, LY3372689
Aldeyra shows FDA-rejected reproxalap improves eye discomfort in new phase 3 study
Fierce Biotech
Thursday, August 8, 2024 - 10:25pm
tags:
Aldeyra Therapeutics, dry eye disease, reproxalap, FDA
Gilead quarterly profit beats Street estimates, revenue up 5%
Yahoo/Reuters
Thursday, August 8, 2024 - 10:24pm
tags:
Gilead Sciences, earnings
FDA approves Citius' therapy for rare blood cancer
Reuters
Thursday, August 8, 2024 - 10:19pm
tags:
Citius Pharmaceuticals, FDA, Lymphir, cutaneous T-cell lymphoma
Will Magenta Medical’s Elevate Disrupt the MCS Market?
Medical Devices and Diagnostics Industry
Thursday, August 8, 2024 - 10:17pm
tags:
Medtech, Magenta Medical, MCS, Elevate, JNJ, Impella
As Novavax comes full circle, it's 'actively exploring' sale of Czech manufacturing plant
Fierce Pharma
Thursday, August 8, 2024 - 10:15pm
tags:
Novavax, drug manufacturing, czech republic
Lilly boosts outlook on rising Zepbound revenue
BioPharma Dive
Thursday, August 8, 2024 - 11:19am
tags:
Eli Lilly, earnings, Zepbound
Satellos to commence Phase I trial for DMD drug
Clinical Trials Arena
Thursday, August 8, 2024 - 11:18am
tags:
Satellos Bioscience, DMD, clinical trials, SAT-3247
Gardasil Chinese Distribution Issue Still a Mystery to Analysts
BioSpace
Thursday, August 8, 2024 - 11:12am
tags:
Merck, Gardasil, vaccines, HPV, China
Guardant Health Q2 Losses Rise Amid Revenue Growth
Motley Fool
Thursday, August 8, 2024 - 11:09am
tags:
Guardant Health, earnings, diagnostics, Medtech

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.